14 research outputs found
Review of a new report: How is technology addressing the college access challenge? A review of the landscape, opportunities, and gaps
The purpose of this review is to examine and critique a new report on technology in regard to college access. The report itself builds upon a previous Get Schooled report from 2013, using updated information and newer programs and apps. The review summarizes the findings of the author, as well as the compilation of tools and their usefulness for students and families. Centered around the fact that many school districts in low-income areas do not have enough financial resources to fund high school counselor positions, the author suggests supplementing the counselor role with various apps and technology. Although this is not a solution to the issue, the report offers practical resources for both families and professionals in the field of college access. This review critically examines the report and offers a few suggestions omissions in the demographics considered, including students with disabilities and students from bilingual families. Overall the review offers a snapshot of the full report and its application to the field of college access and aims to encourage professionals to utilize the tools provided in the report for both advocacy and practical application
Supplementary Figure S6 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Supplementary Figure</p
Supplementary Data Legends from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Legends for supplementary figures and tables.</p
Supplementary Figure S4 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Supplementary Figure</p
Supplementary Figure S3 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Supplementary Figure</p
Supplementary Table 3 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Safetyscreen assay for C86 performed at eurofins.</p
Supplementary Table 2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Table comparing various key pharmacokinetic parameters (Assay, left column) between C-91 and C-86.</p
Supplementary Figure S7 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Supplementary Figure</p
Supplementary Table 1 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
List of key reagents</p
Supplementary Table 4 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
Plasma pharmacokinetic comparisons of C86, C91, and C99 in mice for parameters outlined in the table.</p